Cross-Sector entity
Citigroup is most often covered alongside Weiss Ratings, which appears in 11 of these 20 stories. That works out to roughly 3 stories per week across a 46-day span. The busiest single day carried 3. Coverage clusters in markets, which accounts for 6 of those 20, with the remainder spread across 9 other categories.
36 verified stories tracked
Last mentioned: 1d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 10 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Citigroup is most often covered alongside Weiss Ratings, which appears in 11 of these 20 stories. That works out to roughly 3 stories per week across a 46-day span. The busiest single day carried 3. Coverage clusters in markets, which accounts for 6 of those 20, with the remainder spread across 9 other categories. This profile follows 20 Cross-Sector stories mentioning Citigroup across the period from July 10, 2026 to August 24, 2026. The tracked stories average 2.1 original sources each. 5% of these stories carry negative sentiment.
Computed from the 20 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Citigroup. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen upgrades BKKT and DEI
Wall Street Zen upgraded Bakkt and Douglas Emmett from sell to hold in research notes issued Saturday morning.
Benchmark cuts BKKT target
Benchmark reduced its Bakkt price target from $19.00 to $12.00 while maintaining a buy rating.
Bakkt reports quarterly results
Bakkt announced EPS of $1.94 and revenue of $170.15 million, missing revenue consensus of $373.27 million.
Wall Street Zen downgrades to Hold
Wall Street Zen cut both Klaviyo and Oceaneering International from Buy to Hold in Saturday research notes.
Citigroup lifts KVYO target
Citigroup raised its Klaviyo price target from $34.00 to $36.00 with a Buy rating.
Cantor Fitzgerald raises DEI target
Cantor Fitzgerald raised its Douglas Emmett target price from $12.00 to $13.00 with a neutral rating.
KVYO analyst revisions
Stephens, BTIG, Stifel, and Truist adjusted price targets on Klaviyo following earnings.
Klaviyo Q2 earnings
Klaviyo reported EPS of $0.19, meeting consensus, and revenue of $370.58 million.
Douglas Emmett reports earnings
Douglas Emmett reported quarterly EPS of negative $0.02.
OII insider sale
SVP Christopher J. Dyer sold 1,200 OII shares at an average price of $47.65 for $57,180.
Weiss upgrades OII
Weiss Ratings raised OII from Buy (B-) to Buy (B).
Barclays lifts OII target
Barclays increased its OII price objective from $39.00 to $47.00 with an Equal Weight rating.
Weiss Ratings upgrades DEI
Weiss Ratings upgraded Douglas Emmett from a sell (d) rating to a sell (d+) rating.
Scotiabank raises DEI target
Scotiabank raised its Douglas Emmett target price from $12.00 to $13.00 with a sector perform rating.
Weiss Ratings upgrades BKKT
Weiss Ratings upgraded Bakkt from a sell (e+) rating to a sell (d-) rating.
Offering Closing
The IPO closes, subject to customary conditions, with net proceeds delivered to the company.
IPO Pricing and Trading Start
Sinda Ltd. announces pricing of 17.75M shares at $12.00 each and shares begin trading on NYSE under ticker “SIND.”
Citigroup raises OII target
Citigroup raised its Oceaneering target from $35.00 to $40.00 with a Neutral rating.
Bakkt director buys 100,000 shares
Director Michael Alfred purchased 100,000 BKKT shares at $7.83 each, totaling $783,000.
Wells Fargo lifts DEI target
Wells Fargo raised its Douglas Emmett price target from $13.00 to $14.00 with an overweight rating.
A Q2 13F filing shows Northwestern Mutual Wealth Management initiated a $106.97M RTX position and an $18.25M Cummins stake. Analysts are raising price targets on both names, reinforcing institutional conviction in industrial cyclicals.
Source: Watch List News · Bbns
Wall Street Zen's sell-to-hold upgrade for Bakkt comes as the stock trades at $7.66 with a $341.53 million market cap. The move follows a 54% revenue miss and a director's $783,000 insider buy, leaving analysts divided on whether this is a bottom or a value trap.
Crypto platform Bakkt's sell-to-hold upgrade masks a brutal year: shares at $7.66 are down 85% from $49.79. A director's insider buy and an extreme beta of 5.91 frame the risk-reward for Web3 investors watching custody and exchange infrastructure.
Source: tickerreport.com · themarketsdaily.com
SaaS and cloud operators are watching Klaviyo as a high-multiple vertical SaaS proxy. Wall Street Zen's Buy-to-Hold cut, after Q2 revenue of $370.58 million and EPS in line, shows how quickly a premium valuation can compress when growth doesn't exceed expectations.
Marketing and AdTech teams relying on Klaviyo face new investor scrutiny after Wall Street Zen cut the stock to Hold despite Q2 revenue of $370.58 million and in-line EPS of $0.19. The downgrade lands as analyst targets diverge while the company trades at a 895.95 P/E, raising questions about martech spending sustainability.
Wall Street Zen downgraded both Oceaneering International and Klaviyo from Buy to Hold, spotlighting two $5 billion market-cap companies with vastly different P/E ratios—14.59 for OII and 895.95 for KVYO. The ratings actions come as consensus targets diverge from current prices.
Source: dailypolitical.com · themarketsdaily.com
SoFi Technologies shares jumped 3.7% on August 4, 2026, even as multiple analysts slashed price targets, creating a tension between market momentum and cautious research. With a PE of 38.96, beta of 2.17, and consensus Hold rating, the fintech’s next move hinges on whether profitability can catch up with valuation.
Source: tickerreport.com · dailypolitical.com
Wells Fargo lowered Check Point's target to $130, highlighting a divided analyst community with an average target of $149.48. The stock's depressed valuation and low beta present a potential value opportunity against high-growth cyber peers.
Source: dailypolitical.com · themarketsdaily.com
Curbline Properties' new 52-week high and 460% earnings beat spotlight the vitality of convenience retail real estate, a prime candidate for proptech innovation. Investors should weigh its stretched 101 P/E against low debt and tech-driven growth potential.
Source: dailypolitical.com · tickerreport.com
Spyglass Pharma's stock plunges to a new 52-week low of $17.56 despite a consensus 'Moderate Buy' rating and an average analyst target of $45. For biotech investors, the 156% upside potential must be weighed against a recent earnings miss and a downgrade to sell, raising questions about near-term pipeline catalysts.
Source: tickerreport.com · dailypolitical.com
Hut 8, a leading Bitcoin miner, saw call options volume explode 30% above average, even as insiders dumped shares and earnings underscored operational leverage. With analyst consensus remaining a Moderate Buy at $121.26 target, the options surge offers a high-stakes crypto-proxy bet for digital asset investors.
Source: tickerreport.com · dailypolitical.com
Zalando SE (ZLNDY) shares plunged 7% on Friday with a minuscule 205 shares traded on the OTC market, highlighting the extreme liquidity risks of trading European e-commerce ADRs. Despite analyst upgrades and a $3.52B revenue quarter, the gap-down on such low volume is more a technical artifact than a fundamental signal. Retail investors must weigh the thin order book against the Moderate Buy consensus.
Source: themarketsdaily.com · tickerreport.com
Coca-Cola’s selection of JPMorgan and Citi for its 2027 Indian bottler IPO underscores a lucrative equity capital markets wave in India, with $1.32B revenue unit offering a valuable mandate. The deal, also involving Kotak and Morgan Stanley, adds to a string of multinational carve-outs listing in Mumbai.
Source: thehindubusinessline.com · economictimes.indiatimes.com
After years of waiting, venture-backed companies finally have an open exit window: U.S. IPOs raised a record $104.8 billion in Q2 2026, led by SpaceX. The flood of liquidity promises to unlock stalled VC returns and fuel the next generation of startup funding.
The investment banking machine is roaring back: fees at the biggest U.S. lenders vaulted 45% YoY in Q2, propelled by a record $104.8 billion in IPO proceeds. This broad-based resurgence signals a turning point for bank earnings and sets a bullish tone for financial sector stocks.
Five of America's largest banks shattered earnings expectations for Q2 2026, led by JPMorgan Chase's historic $21.2 billion profit. A confluence of high interest rates, robust trading, and a surge in dealmaking drove the record profits, while stable consumer credit capped loan losses. Investors are now eyeing Morgan Stanley's upcoming report and potential regulatory tailwinds for sustained momentum.
Source: wlac.iheart.com · kwhn.iheart.com
The U.S. Department of Justice is investigating JPMorgan Chase and Citigroup for potential sanctions and money-laundering violations tied to Iran’s Supreme Leader. The probe exposes critical compliance gaps and could lead to substantial civil penalties or deferred prosecution agreements.
Source: caribbeanherald.com · theusnews.com
A dramatic drop in short bets against Hugo Boss signals shifting investor sentiment in luxury retail. With revenue beating estimates and tariff concerns looming, is the luxury sector showing unexpected resilience?
Source: MarketBeat
Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
Wells Fargo’s $225 target is the lowest among major banks, yet ResMed’s average analyst target of $270.64 implies a 23.2% upside. Markets weigh defensive balance sheet qualities against emerging therapeutic competition.
